HK1211985A1 - Methods for the production of ansamitocins - Google Patents

Methods for the production of ansamitocins

Info

Publication number
HK1211985A1
HK1211985A1 HK15112783.9A HK15112783A HK1211985A1 HK 1211985 A1 HK1211985 A1 HK 1211985A1 HK 15112783 A HK15112783 A HK 15112783A HK 1211985 A1 HK1211985 A1 HK 1211985A1
Authority
HK
Hong Kong
Prior art keywords
ansamitocins
production
methods
Prior art date
Application number
HK15112783.9A
Other languages
English (en)
Chinese (zh)
Inventor
辛西亞‧郭
格雷厄姆‧
‧賓
韋恩‧
‧威德森
Original Assignee
Immunogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36692550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1211985(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immunogen Inc filed Critical Immunogen Inc
Publication of HK1211985A1 publication Critical patent/HK1211985A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK15112783.9A 2005-01-19 2015-12-29 Methods for the production of ansamitocins HK1211985A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/037,104 US7432088B2 (en) 2003-05-08 2005-01-19 Methods for the production of ansamitocins

Publications (1)

Publication Number Publication Date
HK1211985A1 true HK1211985A1 (en) 2016-06-03

Family

ID=36692550

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112783.9A HK1211985A1 (en) 2005-01-19 2015-12-29 Methods for the production of ansamitocins

Country Status (27)

Country Link
US (1) US7432088B2 (lt)
EP (2) EP1838863A4 (lt)
JP (1) JP5106120B2 (lt)
KR (3) KR20120099734A (lt)
CN (2) CN101103120A (lt)
AU (1) AU2005325166B2 (lt)
BR (1) BRPI0519624B8 (lt)
CA (2) CA2834033C (lt)
CR (1) CR9228A (lt)
CY (1) CY1121372T1 (lt)
DK (1) DK2514828T3 (lt)
EA (1) EA012524B1 (lt)
ES (1) ES2710875T3 (lt)
HK (1) HK1211985A1 (lt)
HU (1) HUE042312T2 (lt)
IL (2) IL183918A (lt)
LT (1) LT2514828T (lt)
MX (1) MX2007008069A (lt)
NO (1) NO342876B1 (lt)
NZ (2) NZ583446A (lt)
PL (1) PL2514828T3 (lt)
PT (1) PT2514828T (lt)
SG (1) SG158905A1 (lt)
SI (1) SI2514828T1 (lt)
TR (1) TR201901647T4 (lt)
WO (1) WO2006078368A1 (lt)
ZA (1) ZA200704918B (lt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE446317T1 (de) 2001-05-11 2009-11-15 Ludwig Inst For Cancer Res Ltd Spezifische bindungsproteine und ihre verwendung
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
US20070095203A1 (en) * 2005-10-07 2007-05-03 Paris Henry G Method to Remove an Agent Using a Magnetic Carrier from the Gaseous Phase of a Process
US20070135629A1 (en) * 2005-12-08 2007-06-14 Millennium Pharmaceuticals, Inc. Isolation of ansamitocins
TW200812687A (en) * 2006-07-10 2008-03-16 Sicor Inc Apparatus for the separation of a resin from a reaction mixture
CN100420754C (zh) * 2006-10-26 2008-09-24 浙江海正药业股份有限公司 一种制备蒽莎姆菌素的方法
JP5276017B2 (ja) 2007-01-25 2013-08-28 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド Ｅｇｆｒ変異体仲介性疾患の治療における抗ｅｇｆｒ抗体の使用
CN101688229B (zh) 2007-03-15 2013-06-12 路德维格癌症研究所 包含egfr抗体和src抑制剂的组合物及其在制备用于治疗哺乳动物癌症的药物中的用途
PE20090481A1 (es) 2007-07-16 2009-05-18 Genentech Inc Anticuerpos anti-cd79b e inmunoconjugados humanizados y metodos de uso
RS52305B (en) 2007-07-16 2012-12-31 Genentech Inc. ANTI-CD79B ANTIBODIES AND IMMUNOCONCULATES AND METHODS OF USE
CN101896503B (zh) 2007-08-14 2018-05-22 路德维格癌症研究所有限公司 靶向egf受体的单克隆抗体175及其衍生物和用途
ES2587392T3 (es) 2008-01-31 2016-10-24 Genentech, Inc. Anticuerpos anti-CD79b e inmunoconjugados y métodos de uso
HUE025507T2 (en) 2008-03-18 2016-02-29 Genentech Inc Combinations of anti-HER2 antibody-drug conjugate and chemotherapeutic agents and methods for their use
CN101319241B (zh) * 2008-07-17 2011-03-30 上海交通大学 安丝菌素的固体发酵方法
SG174992A1 (en) 2009-04-01 2011-11-28 Genentech Inc Anti-fcrh5 antibodies and immunoconjugates and methods of use
US20110165155A1 (en) 2009-12-04 2011-07-07 Genentech, Inc. Methods of treating metastatic breast cancer with trastuzumab-mcc-dm1
CN101921817A (zh) * 2010-09-07 2010-12-22 上海交通大学 安莎霉素发酵产量提高方法
US20120121615A1 (en) 2010-11-17 2012-05-17 Flygare John A Alaninyl maytansinol antibody conjugates
US8852435B2 (en) * 2011-11-29 2014-10-07 Therapeutics Proteins International, LLC Purification and separation treatment assembly (PASTA) for biological products
CN103255184B (zh) * 2012-02-15 2016-01-27 百奥泰生物科技(广州)有限公司 生产安丝菌素的发酵培养基
CN103805648B (zh) * 2012-11-13 2017-09-15 百奥泰生物科技(广州)有限公司 高产安丝菌素发酵工艺
US10208125B2 (en) 2013-07-15 2019-02-19 University of Pittsburgh—of the Commonwealth System of Higher Education Anti-mucin 1 binding agents and uses thereof
TWI541022B (zh) 2013-12-18 2016-07-11 應克隆公司 針對纖維母細胞生長因子受體－３（ｆｇｆｒ３）之化合物及治療方法
TW201711702A (zh) 2015-06-04 2017-04-01 應克隆公司 使用針對纖維母細胞生長因子受體３（ｆｇｆｒ３）之化合物的療法
SI3319995T1 (sl) 2015-07-07 2019-07-31 F. Hoffmann-La Roche Ag Kombinirana terapija s konjugatom protitelo anti-HER-2 in zdravilo ter zaviralcem bcl-2
CN105907681B (zh) * 2016-05-30 2019-11-19 苏州康聚生物科技有限公司 一种高产安丝菌素p-3的突变株及安丝菌素p-3的制备方法
CN108276427A (zh) * 2018-01-14 2018-07-13 常州大学 一种安丝菌素p-3的提取与分离纯化方法
CN108330113B (zh) * 2018-03-08 2019-05-28 山东省医药生物技术研究中心（山东省病毒研究所） 一株高底物专一性酰基转移酶的珍贵束丝放线菌及其应用
CN113444106A (zh) * 2020-03-25 2021-09-28 重庆乾泰生物医药有限公司 一种高纯度安丝菌素的制备方法
CN112630368A (zh) * 2020-12-18 2021-04-09 卓和药业集团有限公司 安丝菌素含量的高效液相色谱检测分析方法
CN117597450A (zh) * 2021-06-18 2024-02-23 杭州中美华东制药有限公司 安丝菌素p-3的提纯方法
CN115477658A (zh) * 2022-10-12 2022-12-16 道中道（菏泽）制药有限公司 一种有效降低安丝菌素p-3杂质的结晶方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2241418A1 (de) 1972-08-23 1974-03-07 S Morris Kupchan Antileukaemische ansamakrolide
JPS6010718B2 (ja) 1977-03-31 1985-03-19 武田薬品工業株式会社 メイタンシノ−ル，メイタナシンおよびメイタンシノ−ル・プロピオネ−トの製造法
US4151042A (en) 1977-03-31 1979-04-24 Takeda Chemical Industries, Ltd. Method for producing maytansinol and its derivatives
JPS53130495A (en) * 1977-04-01 1978-11-14 Takeda Chem Ind Ltd Antibiotic substance c-15003
JPS6034556B2 (ja) * 1977-03-31 1985-08-09 武田薬品工業株式会社 抗生物質ｃ−１５００３
US4162940A (en) 1977-03-31 1979-07-31 Takeda Chemical Industries, Ltd. Method for producing Antibiotic C-15003 by culturing nocardia
JPS53124692A (en) 1977-04-01 1978-10-31 Takeda Chem Ind Ltd Preparation of maytansinol, maytansine, and maytansinol, propionate
US4137230A (en) 1977-11-14 1979-01-30 Takeda Chemical Industries, Ltd. Method for the production of maytansinoids
JPS6016236B2 (ja) 1977-11-18 1985-04-24 武田薬品工業株式会社 抗生物質ｃ―１５００３ ｐ―３の製造法
US4307016A (en) 1978-03-24 1981-12-22 Takeda Chemical Industries, Ltd. Demethyl maytansinoids
JPS5529972A (en) 1978-08-24 1980-03-03 Takeda Chem Ind Ltd Preparation of maytansinol
JPS55102583A (en) 1979-01-31 1980-08-05 Takeda Chem Ind Ltd 20-acyloxy-20-demethylmaytansinoid compound
JPS55162791A (en) 1979-06-05 1980-12-18 Takeda Chem Ind Ltd Antibiotic c-15003pnd and its preparation
JPS5645483A (en) 1979-09-19 1981-04-25 Takeda Chem Ind Ltd C-15003phm and its preparation
JPS56102793A (en) * 1979-12-28 1981-08-17 Takeda Chem Ind Ltd Preparation of antibiotic c-15003 p-3
JPS57192389A (en) 1981-05-20 1982-11-26 Takeda Chem Ind Ltd Novel maytansinoid
CA2006408A1 (en) 1988-12-27 1990-06-27 Susumu Iwasa Bispecific monoclonal antibody, its production and use
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
DE10012120A1 (de) 2000-03-13 2001-09-27 Ktb Tumorforschungs Gmbh Therapeutische und diagnostische Ligandensysteme mit Transportmolekülbindenden Eigenschaften und diese enthaltende Arzneimittel
US6573074B2 (en) * 2000-04-12 2003-06-03 Smithkline Beecham Plc Methods for ansamitocin production
WO2001095943A2 (en) 2000-06-14 2001-12-20 Medarex, Inc. Prodrug compounds with an oligopeptide having an isoleucine residue
US6333410B1 (en) 2000-08-18 2001-12-25 Immunogen, Inc. Process for the preparation and purification of thiol-containing maytansinoids
US20020156274A1 (en) 2001-03-16 2002-10-24 Terfloth Gerald J. Process for preparing maytansinol
US6441163B1 (en) 2001-05-31 2002-08-27 Immunogen, Inc. Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
US6790954B2 (en) * 2002-01-29 2004-09-14 Immunogen, Inc. Mutant Actinosynnema pretiosum strain with increased maytansinoid production
WO2005020883A2 (en) * 2003-05-08 2005-03-10 Immunogen, Inc. Methods for the production of ansamitocins
US7276497B2 (en) 2003-05-20 2007-10-02 Immunogen Inc. Cytotoxic agents comprising new maytansinoids

Also Published As

Publication number Publication date
PT2514828T (pt) 2019-02-15
ZA200704918B (en) 2008-11-26
MX2007008069A (es) 2007-08-21
CY1121372T1 (el) 2020-05-29
WO2006078368A1 (en) 2006-07-27
DK2514828T3 (en) 2019-03-11
KR20120099734A (ko) 2012-09-11
CN101103120A (zh) 2008-01-09
KR20130051019A (ko) 2013-05-16
NZ555437A (en) 2010-04-30
KR20070099576A (ko) 2007-10-09
JP5106120B2 (ja) 2012-12-26
SI2514828T1 (sl) 2019-03-29
ES2710875T3 (es) 2019-04-29
CA2595024C (en) 2014-02-04
US7432088B2 (en) 2008-10-07
IL215686A0 (en) 2011-11-30
CA2595024A1 (en) 2006-07-27
BRPI0519624A2 (pt) 2009-02-25
AU2005325166B2 (en) 2012-02-02
TR201901647T4 (tr) 2019-02-21
CA2834033A1 (en) 2006-07-27
JP2008526267A (ja) 2008-07-24
CR9228A (es) 2008-03-31
EP2514828A3 (en) 2013-07-03
NO342876B1 (no) 2018-08-20
IL183918A0 (en) 2007-10-31
EP2514828B1 (en) 2018-11-14
IL183918A (en) 2013-07-31
EP1838863A4 (en) 2011-10-05
IL215686A (en) 2013-07-31
EA200701310A1 (ru) 2008-06-30
EP2514828A2 (en) 2012-10-24
EA012524B1 (ru) 2009-10-30
NZ583446A (en) 2011-08-26
CA2834033C (en) 2017-01-24
LT2514828T (lt) 2019-02-25
PL2514828T3 (pl) 2019-04-30
US20050170475A1 (en) 2005-08-04
SG158905A1 (en) 2010-02-26
AU2005325166A1 (en) 2006-07-27
NO20074222L (no) 2007-10-18
BRPI0519624B8 (pt) 2021-05-25
BRPI0519624B1 (pt) 2021-01-19
EP1838863A1 (en) 2007-10-03
HUE042312T2 (hu) 2019-06-28
CN104745655A (zh) 2015-07-01
KR101515873B1 (ko) 2015-04-29

Similar Documents

Publication Publication Date Title
HK1211985A1 (en) Methods for the production of ansamitocins
IL181303A0 (en) Method for the production of dihydropteridinones
ZA200711016B (en) Method for production of 1-alkyl-3-phenyluracils
PL1795576T3 (pl) Sposób wytwarzania węglowodorów
PL1903019T3 (pl) Sposób wytwarzania izoolefin
EP1861408A4 (en) PROCESS FOR PRODUCING HYDROCHLOROSILANES
IL185757A0 (en) Methods of decreasing calcifcation
EP1874948A4 (en) PROCESS FOR THE PREPARATION OF Y-GLUTAMYLCYSTEIN
PT1928928T (pt) Método para a produção de poliisocianatos
GB0622342D0 (en) Novel compounds and methods for their production
IL184800A0 (en) Method for the production of losartan
IL181339A0 (en) Method for the production of diarylcycloalkyl derivatives
GB0606554D0 (en) Novel compounds and methods for their production
GB0606542D0 (en) Novel compounds and methods for their production
HK1134925A1 (en) Method for the production of benzofuran-2-carboxamides
PL378004A1 (pl) Sposób wytwarzania R-pantolaktonu
PL378375A1 (pl) Sposób wytwarzania nanoceramik BaTiO₃
PL373928A1 (pl) Sposób wytwarzania imatinibu
ZA200700282B (en) Method for the production of dihydropteridinones
PL376691A1 (pl) Sposób wytwarzania pochodnych N-fenylo-2- pirymidynoamin
AU2005901571A0 (en) Process for the production of gamma-glutamylcysteine
AU2005901749A0 (en) Improved production of titana
GB0509846D0 (en) Production method
GB0616637D0 (en) Novel compounds and methods for their production
GB0609132D0 (en) Novel compounds and methods for their production